当前位置:Public Access >页面
Chinese/English
Among the patients who started antiviral therapy during AIDS, To evaluate the safety and effectiveness of the treatment based on integrase inhibitors compared with the treatment based on non-nucleoside reverse transcriptase inhibitors

ChiCTR注册号:

Reg No. in ChiCTR:

ChiCTR2300073463

研究题目:

Among the patients who started antiviral therapy during AIDS, To evaluate the safety and effectiveness of the treatment based on integrase inhibitors compared with the treatment based on non-nucleoside reverse transcriptase inhibitors

Study title:

Among the patients who started antiviral therapy during AIDS, To evaluate the safety and effectiveness of the treatment based on integrase inhibitors compared with the treatment based on non-nucleoside reverse transcriptase inhibitors

 注册状况:

 Registration:

False

注册机构:

中国临床试验注册中心

Name of the Registry:

Chinese Clinical Trial Registry

项目负责人:

中国临床试验注册中心

Corresponding person:

Chinese Clinical Trial Registry

电话:

Telephone:

18017500639

电子邮件

Email

qtchenjun@163.com

通讯地址:

上海市金山区漕廊公路2901号

Address:

No.2901 Caolang Highway, Jinshan District, Shanghai

邮政编码

Postcode

201508

项目负责人所有单位:

上海市公共卫生临床中心

Institution:

Shanghai Public Health Clinical Center

批准本研究的伦理委员会名称:

上海市公共卫生临床中心伦理委员会

Name of the ethic committee:

Shanghai Public Health Clinical Center Ethics Offi

研究疾病:

Study Ailment:

研究所处阶段:

Study phase:

Post-market

研究类型:

Type of Study:

Diagnostic Accuracy Test

研究团队:

陈军 唐建琴 邹美银 陆兴 陈维迪 杨亦德 袁刚 解奕瑞 师金川 张展 张军 蓝珂 张振江 盛丽娜 臧玮 苏菲菲 袁子清 主要研究者:陈军 教授

Research team:

Chen jun Tang jianqin Zou Meiyin Lu xing Chen weidi Yang Yide Yuan gang Jie yirui Shi Jinchuan Zhan Zhang Zhang Jun Lanke zhang zhenjiang Sheng Lina Zangwei Su Feifei Yuan ziqing Principal investigator: Professor Chen Jun.

研究实施地点:

Site of Study:

国家(地区):

中国

省(直辖市):

上海

市(区县):

上海

Country/Area:

China

Province:

Shanghai

City:

Shanghai
单位 上海市公共卫生临床中心
Institution Shanghai Public Health Clinical Center

预计起止时间:

Planned Duration:

2023/7/1 0:00:00-2024/12/31 0:00:00